Purpose: Several studies and papers have reported good short-term results for using 120W HPS laser PVP. Here we report the short-term and long-term clinical outcomes analysis with efficacy and safety of 120W HPS laser PVP for the treatment of BPH. Results: The mean age at the surgery; 70.35±8.28, mean prostate size; 46.56±21.11 ml, and mean PSA was 4.16±4.35 ng/ml. Mean operation time was 41.8±34.1 min, and mean lasing time was 19.8±11.3 min. Mean applied energy was 134,294.9±225,211.5 J. Thirty cases of co-operation were done. Mean catheter indwelling time was 0.84±0.36 day, and mean hospital stay was 1.1±0.2 day. The blood loss was minimal so transfusions were not needed. The baseline IPSS-sum; 19.61±9.13, QoL score; 4.28±1.02, Qmax; 7.94±5.51 ml/sec, PVR; 101.62±102.58 ml, At 1 month, IPSS-sum; 8.64±7.34, QoL score; 2.19±1.48, Qmax; 13.32±8.94 ml/sec, PVR; 32.54±46.07 ml was noted. At 12 months, IPSS-sum; 8.33±5.04, QoL score; 1.33±1.08, Qmax; 15.75±2.90 ml/sec, PVR; 21.56±31.28 ml was noted. Within 1 month of operation, 18 cases of dysuria and 27 cases of retention were reported but these were resolved with medication and observation. Compared with preoperative values, there were statistical improvements after the operation.

